De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Quest Diagnostics Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Quest Diagnostics heeft een totaal eigen vermogen van $6.7B en een totale schuld van $4.4B, wat de schuld-eigenvermogensverhouding op 65.4% brengt. De totale activa en totale passiva bedragen respectievelijk $13.9B en $7.1B. De EBIT Quest Diagnostics is $1.3B waardoor de rentedekking 8 is. Het heeft contanten en kortetermijnbeleggingen van $271.0M.
Belangrijke informatie
65.4%
Verhouding schuld/eigen vermogen
US$4.41b
Schuld
| Rente dekkingsratio | 8x |
| Contant | US$271.00m |
| Aandelen | US$6.74b |
| Totaal verplichtingen | US$7.15b |
| Totaal activa | US$13.88b |
Recente financiële gezondheidsupdates
These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well
Aug 30
We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 17Recent updates
These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well
Aug 30Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?
Aug 12Quest Diagnostics: Beat Down After Beating Q2 Estimates
Jul 28The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)
Jul 12Quest Diagnostics: On A Quest For Growth
Jul 12Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14Quest Diagnostics: Let's Keep Waiting
May 08Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares
Apr 02Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Mar 15Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75
Feb 06Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price
Dec 24Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?
Dec 06Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall
Nov 18Quest Diagnostics: Moving Past Covid
Oct 25Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Sep 04Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
Aug 15Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
Aug 13Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jul 11Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics: Healthier Diagnosis
May 30Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?
May 24Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
May 09An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued
Mar 22What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Feb 19Why Quest Diagnostics Isn't A 'Buy', My Oh My
Feb 14Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's
Feb 05Quest Diagnostics Q4 2022 Earnings Preview
Feb 01Quest Diagnostics' unit Pack Health to expand Alabama facility
Jan 17Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital Are Showing Encouraging Signs At Quest Diagnostics (NYSE:DGX)
Jan 03An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 46% Undervalued
Dec 04Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $2.0B ) DGX } overtreffen de korte termijn passiva ( $2.0B ).
Langlopende schulden: De kortetermijnactiva van DGX ( $2.0B ) dekken de langetermijnschulden ( $5.1B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 61.4% ) DGX wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van DGX is de afgelopen 5 jaar gedaald van 71.2% naar 65.4%.
Schuldendekking: De schuld van DGX wordt goed gedekt door de operationele kasstroom ( 28.3% ).
Rentedekking: De rentebetalingen op de schuld van DGX worden goed gedekt door EBIT ( 8 x dekking).